Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 25 October 2006. doi:10.1136/hrt.2005.086041
Heart 2007;93:500-505
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

CARDIOVASCULAR SURGERY

Clinical and echocardiographic assessment of the Medtronic Advantage aortic valve prosthesis: the Scandinavian multicentre, prospective study

Rune Haaverstad1, Nicola Vitale1, Asbjørn Karevold1, Giangiuseppe Cappabianca1, Arve Tromsdal1, Peter Skov Olsen2, Lars Köber2, Halfdan Ihlen3, Kjell Arne Rein3, Jan L Svennevig3

1 Departments of Cardiothoracic Surgery, Trondheim University Hospital, Trondheim, Norway
2 Departments of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark
3 Departments of Cardiothoracic Surgery, Rikshospitalet, Oslo, Norway

Correspondence to:
Professor R Haaverstad
St Elisabeth Cardiothoracic Centre, Trondheim University Hospital, N 7018 Trondheim, Norway; rune.haaverstad{at}ntnu.no

ABSTRACT

Objective: The aim of this report is the prospective, multicentre evaluation of clinical results and haemodynamic performance of the Medtronic Advantage aortic valve prosthesis.

Methods: From April 2001 to June 2003, 166 patients (male:female 125:41; mean (SD) age 61.8 (11.8) years) received an aortic advantage valve prosthesis. Complete cumulative follow-up was 242.7 patient-years (maximum 3.2; mean 1.6 years). Postoperatively, patients underwent early (within 30 days) and 1 year transthoracic echocardiography.

Results: 30 day mortality was 2.4% (n = 4). Kaplan–Meier estimates of freedom from complications and linearised rates were as follows: 96.9 (1.6)% survival; 94.7 (1.3)% (2.06 patients/year) thrombo-embolism; 99.4 (0.6)% (0.4 patients/year) bleeding; 98.8 (0.9)% (0.8 patients/year) non-structural valve dysfunction; 98.8 (0.9)% (0.8 patients/year) reoperation. Valvular mean pressure gradients ranged from 16 (3) mm Hg for size 19 to 7 (2) mm Hg for size 27 and the corresponding effective orifice areas ranged from 1.2 (0.25) to 3.2 (0.66) cm2. In all, left ventricular mass significantly decreased (p<0.001) and fractional shortening increased (p<0.001) from postoperative to 1 year echocardiography.

Conclusions: Haemodynamic performance and early clinical results of Medtronic advantage in the aortic position were satisfactory and comparable with those of other bileaflet valves in current clinical use.

Abbreviations: EOA, effective orifice area; EOAI, effective orifice area index; INR, international normalised ratio; LVM, left ventricular mass; LVOT, left ventricular outflow tract; NYHA, New York Heart Association; PILVOT, performance index calculated using the left ventricular outflow tract area; PITAA, performance index calculated using the tissue annulus area


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Haaverstad, R., Vitale, N., Tromsdal, A., Hegbom, K., Karevold, A. (2007). Intermittent incomplete closure of Medtronic Advantage aortic valve leaflets causes unnecessary reoperation. J. Thorac. Cardiovasc. Surg. 134: 791-792 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.